Company page
Oryzon Genomics Sa
Oryzon Genomics Sa is a public biotechnology company based in Spain, trading under the ticker ORY. The company focuses on the development of innovative therapies for neurodegenerative diseases and cancer. With a market capitalization of approximately €286.77 million, Oryzon is positioned in the growing biotech sector.
- Ticker
- ORY:BME
- Asset type
- Stock
- Market cap
- $286.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BME
- Currency
- EUR